₹ 1,519.40
-2.00 (-0.13%)
F
Fredun Pharmaceuticals
₹ 1,519.40
Fredun Pharmaceuticals EPS Summary (consolidated)
The latest quarterly EPS of Fredun Pharmaceuticals as of Q2 Sep 2026 stands at ₹10.99. This is a 53.86% fall quarter on quarter and 44.99% fall same quarter last year. For the FY2026 the EPS of Fredun Pharmaceuticals stands at ₹66.81. This is a 59.91% growth compared with FY2025.
Fredun Pharmaceuticals EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

